Kepos Capital’s Veraxa Biotech AG Warrants VRXAW Stock Holding History

Kepos Capital’s Portfolio VRXAW Stock Details VRXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12K	Buy	+200,000	New	+$20.9K	0.01%	141

Other funds holding VRXAW

Yorkville Advisors Global Mountainside, New Jersey $133M AUM 33.08% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $18B AUM 27.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 22.91% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Kepos Capital's VRXAW Position: Q3 2026 in Review

Kepos Capital opened a new position in Veraxa Biotech AG Warrants (VRXAW) in Q3 2026: 200,000 shares worth $12K. The stake represents 0.01% of the portfolio and ranks #141 among its holdings.

15 funds tracked by Wall St. Rank hold VRXAW as of Q3 2026.

Kepos Capital held 200,000 shares of Veraxa Biotech AG Warrants worth $12K as of Q3 2026.
Veraxa Biotech AG Warrants was a new Kepos Capital position in Q3 2026.
Veraxa Biotech AG Warrants made up 0.01% of Kepos Capital's portfolio in Q3 2026, its #141 holding.
15 funds tracked by Wall St. Rank held Veraxa Biotech AG Warrants as of Q3 2026.

Based on Kepos Capital's 13F filing for Q3 2026, filed 13 Nov 2026.